Park Circle Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$710K Hold
11,700
0.66% 33
2025
Q4
$631K Hold
11,700
0.55% 37
2025
Q3
$528K Hold
11,700
0.44% 41
2025
Q2
$542K Hold
11,700
0.46% 40
2025
Q1
$714K Hold
11,700
0.63% 34
2024
Q4
$662K Hold
11,700
0.59% 37
2024
Q3
$605K Buy
+11,700
New +$549K 0.53% 39
2023
Q4
Sell
-6,700
Closed -$389K 114
2023
Q3
$389K Hold
6,700
0.36% 48
2023
Q2
$428K Hold
6,700
0.4% 47
2023
Q1
$464K Hold
6,700
0.45% 45
2022
Q4
$482K Hold
6,700
0.45% 46
2022
Q3
$476K Hold
6,700
0.49% 46
2022
Q2
$516K Hold
6,700
0.42% 55
2022
Q1
$489K Sell
6,700
-3,300
-33% -$222K 0.41% 51
2021
Q4
$624K Hold
10,000
0.49% 44
2021
Q3
$592K Hold
10,000
0.45% 44
2021
Q2
$668K Buy
+10,000
New +$652K 0.5% 39
2017
Q4
Sell
-800
Closed -$45K 83
2017
Q3
$45K Hold
800
0.03% 67
2017
Q2
$45K Hold
800
0.03% 73
2017
Q1
$44K Buy
800
+200
+33% +$11K 0.03% 68
2016
Q4
$35K Buy
600
+300
+100% +$16.4K 0.02% 79
2016
Q3
$16K Buy
+300
New +$19.3K 0.01% 91

Other funds holding BMY

Park Circle Company's BMY Position: Q1 2026 in Review

Park Circle Company held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 11,700 shares worth $710K. The position accounts for 0.66% of the portfolio, ranked #33.

Park Circle Company first reported a position in BMY in Q3 2016 and has held it in 22 quarters since. The position peaked at $714K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Park Circle Company held 11,700 shares of Bristol-Myers Squibb worth $710K as of Q1 2026.
  • Park Circle Company left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.66% of Park Circle Company's portfolio in Q1 2026, its #33 holding.
  • Park Circle Company first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 22 quarters since.
  • Park Circle Company's Bristol-Myers Squibb position peaked at $714K in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Park Circle Company's 13F filing for Q1 2026, filed 14 May 2026.